Clinical Trials Browser

Phase 2 × OTHER × Advanced Esophageal Squamous Cell Cancer × Clear all

NCT05323890 2023-03-14

Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.

Phase 2 Unknown

Gastrointestinal

Advanced Esophageal Squamous Cell Cancer

NCT04437212 2020-06-26

Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Advanced Esophageal Squamous Cell Cancer